Survey of Ophthalmology
Volume 45 , Pages S250-S255 , May 2001

New Horizons in Neuroprotection

  • Rita Naskar, PhD
    • ,
  • Evan B Dreyer, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint address: Evan Benjamin Dreyer, MD, PhD, Scheie Eye Institute, 51 North 39th Street, Philadelphia, PA 19104 USA

References 

  1. Baumgartner BJ, Shine HD. Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus-mediated expression of glial cell-line- derived neurotrophic factor. J Neurosci Res. 1998;54:766–777
  2. Berkelaar M, Clarke DB, Wang YC, et al.  Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994;14:4368–4374
  3. Bilak MM, Shifrin DA, Corse AM, et al.  Neuroprotective utility and neurotrophic action of neurturin in postnatal motor neurons (comparison with GDNF and persephin). Mol Cell Neurosci. 1999;13:326–336
  4. Bonfoco E, Krainc D, Ankarcrona M, et al.  Apoptosis and necrosis (two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures). Proc Natl Acad Sci USA. 1995;92:7162–7166
  5. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623–634
  6. Davis KE, Robinson MB: PDGF increases EAAC1-mediated glutamate transport activity and cell surface expression in C6 glioma. Soc Neurosci Abstracts 28:826.12, 1998
  7. Dawson TM, Dawson VL, Snyder SH. Molecular mechanisms of nitric oxide actions in the brain. Ann NY Acad Sci. 1994;738:76–85
  8. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain (the free radical, nitric oxide). Ann Neurol. 1992;32:297–311[see comments]
  9. Dighiero P, Reux I, Hauw JJ, et al.  Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett. 1994;166:31–34
  10. Djamgoz MB, Aguilo R, Greenstreet EH, et al.  Histochemistry of NADPH-diaphorase—a marker for neuronal nitric oxide synthase—in the carp retina. Neurochem Int. 1996;28:283–291
  11. Doble A. The role of excitotoxicity in neurodegenerative disease (implications for therapy). Pharmacol Ther. 1999;81:163–221
  12. Dreyer EB, Zhang D, Lipton SA. Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death. NeuroReport. 1995;6:942–944
  13. Dykens JA, Stern A, Trenkner E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J Neurochem. 1987;49:1222–1228
  14. Eastwood SL, Burnet PW, Harrison PJ. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia (a reverse transcriptase-polymerase chain reaction (RT-PCR) study). Brain Res Mol Brain Res. 1997;44:92–98
  15. Estevez AG, Spear N, Manuel SM, et al.  Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci. 1998;18:923–931
  16. Fan D, Ogawa M, Ikeguchi K, et al.  Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro. Neurosci Lett. 1998;248:61–64
  17. Fournier AE, Beer J, Arregui CO, et al.  Brain-derived neurotrophic factor modulates GAP-43 but not T alpha1 expression in injured retinal ganglion cells of adult rats. J Neurosci Res. 1997;47:561–572
  18. Franco-Bourland RE, Guizar-Sahagun G, Garcia GA, et al.  Retinal vulnerability to glutamate excitotoxicity in canine glaucoma (induction of neuronal nitric oxide synthase in retinal ganglion cells). Proc West Pharmacol Soc. 1998;41:201–204
  19. Furukawa K, Estus S, Fu W, et al.  Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways. J Cell Biol. 1997;136:1137–1149
  20. Gegelashvili G, Schousboe A. High affinity glutamate transporters (regulation of expression and activity). Mol Pharmacol. 1997;52:6–15
  21. Gimenez y Ribotta M, Revah F, Pradier L, et al.  Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res. 1997;48:281–285
  22. Gorman AM, Orrenius S, Ceccatelli S. Apoptosis in neuronal cells (role of caspases). NeuroReport. 1998;9:R49–R55
  23. Green DR. Apoptotic pathways (the roads to ruin). Cell. 1998;94:695–698
  24. Haefliger IO, Lietz A, Griesser SM, et al.  Modulation of Heidelberg Retinal Flowmeter parameter flow at the papilla of healthy subjects (effect of carbogen, oxygen, high intraocular pressure, and beta-blockers). Surv Ophthalmol. 1999;43(Suppl 1):S59–S65
  25. Hiroi N, Marek GJ, Brown JR, et al.  Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci. 1998;18:6952–6962
  26. Huang Z, Huang PL, Panahian N, et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883–1885
  27. Ikeda K, Iwasaki Y, Kinoshita M. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse. J Neurol Sci. 1998;160:9–15
  28. Ikonomidou C, Turski L. Neurodegenerative disorders (clues from glutamate and energy metabolism). Crit Rev Neurobiol. 1996;10:239–263
  29. Kermer P, Klocker N, Labes M, Bahr M. Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci. 1998;18:4656–4662
  30. Kowall NW, Beal MF. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons (normal anatomy and alterations in Alzheimers disease). Ann Neurol. 1988;23:105–114
  31. Kreutz MR, Bockers TM, Bockmann J, et al.  Axonal injury alters alternative splicing of the retinal NR1 receptor (the preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival). J Neurosci. 1998;18:8278–8291
  32. Lau KC, So KF, Tay D, Leung MC. NADPH-diaphorase neurons in the retina of the hamster. J Comp Neurol. 1994;350:550–558
  33. Lindholm D, Hamner S, Zirrgiebel U. Neurotrophins and cerebellar development. Perspect Dev Neurobiol. 1997;5:83–94
  34. Lipton SA. Prospects for clinically tolerated NMDA antagonists (open-channel blockers and alternative redox states of nitric oxide). Trends Neurosci. 1993;16:527–532
  35. Lipton SA, Choi YB, Pan ZH, et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626–632[see comments]
  36. Liu B, Neufeld AH. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia. 2000;30:178–186
  37. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol. 1957;58:193–201
  38. Lucius R, Sievers J. YVAD protect post-natal retinal ganglion cells against axotomy-induced but not free radical-induced axonal degeneration in vitro. Brain Res Mol Brain Res. 1997;48:181–184
  39. Lundberg C, Jungles SJ, Mulligan RC: Neuroprotective effects of GDNF as studied by recombinant adeno-associated gene transfer to the adult rat brain. Soc Neurosci Abstracts 24:519.1, 1998
  40. May CA, Hayreh SS, Furuyoshi N, et al.  Choroidal ganglion cell plexus and retinal vasculature in monkeys with laser-induced glaucoma. Ophthalmologica. 1997;211:161–171
  41. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci. 1990;11:379–387
  42. Milton ID, Banner SJ, Ince PG, et al.  Expression of the glial glutamate transporter EAAT2 in the human CNS (an immunohistochemical study). Brain Res Mol Brain Res. 1997;52:17–31
  43. Naskar R, Vorwerk CK, Dreyer EB. Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1940–1944
  44. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115:497–503
  45. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA. 1999;96:9944–9948
  46. Nickells RW, Zack DJ. Apoptosis in ocular disease (a molecular overview). Ophthalmic Genet. 1996;17:145–165
  47. Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol. 1997;235:551–552
  48. Obrenovitch TP. Origins of glutamate release in ischaemia. Acta Neurochir (Wien). 1996;66(Suppl):50–55
  49. Olney JW. Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol. 1969;28:455–474
  50. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature. 1970;227:609–611
  51. Pease ME, McKinnon SJ, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000;41:764–774
  52. Piehl F, Tabar G, Cullheim S. Expression of NMDA receptor mRNAs in rat motoneurons is down-regulated after axotomy. Eur J Neurosci. 1995;7:2101–2110
  53. Quigley HA, McKinnon SJ, Zack DJ, et al.  Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci. 2000;41:3460–3466
  54. Quigley HA, Nickells RW, Kerrigan LA, et al.  Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774–786
  55. Rothstein JD, Van Kammen M, Levey AI, et al.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995;38:73–84
  56. Samarasinghe S, Virgo L, de Belleroche J. Distribution of the N-methyl-D-aspartate glutamate receptor subunit NR2A in control and amyotrophic lateral sclerosis spinal cord. Brain Res. 1996;727:233–237
  57. Schlag BD, Zelenaia O, Grinspan JB: PDGF and EGF induce astrocytic expression of the GLT-1 subtype of glutamate transporter. Soc Neurosci Abstracts 24:826.15, 1998
  58. Scott HL, Tannenberg AE, Dodd PR. Variant forms of neuronal glutamate transporter sites in Alzheimers disease cerebral cortex. J Neurochem. 1995;64:2193–2202
  59. Shareef S, Sawada A, Neufeld AH. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest Ophthalmol Vis Sci. 1999;40:2884–2891
  60. Sisk DR, Kuwabara T. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate. Graefes Arch Clin Exp Ophthalmol. 1985;223:250–258
  61. Sisk DR, Kuwabara T, Kirsch AD. Behavioral recovery in albino rats with glutamate-damaged retinas. Invest Ophthalmol Vis Sci. 1984;25:1124–1128
  62. Small DL, Poulter MO, Buchan AM, Morley P. Alteration in NMDA receptor subunit mRNA expression in vulnerable and resistant regions of in vitro ischemic rat hippocampal slices. Neurosci Lett. 1997;232:87–90
  63. Solary E, Eymin B, Droin N, Haugg M. Proteases, proteolysis, and apoptosis. Cell Biol Toxicol. 1998;14:121–132
  64. Takano M: [Axonal regeneration of retinal ganglion cells]. Nippon Ganka Gakkai Zasshi 100:972–81, 1996
  65. Tapia R. Release and uptake of glutamate as related to excitotoxicity. Rev Bras Biol. 1996;56:165–174

PII: S0039-6257(01)00198-9

Survey of Ophthalmology
Volume 45 , Pages S250-S255 , May 2001

Article Tools